
Chemically competent cells are calcium chloride treated to facilitate attachment of the plasmid DNA to the competent cell membrane. Chemically competent cells are the best solution for general cloning and subcloning application
Market Analysis and Insights: Global Chemically Competent Cells Market
The global Chemically Competent Cells market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Chemically Competent Cells is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Chemically Competent Cells is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Chemically Competent Cells is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Chemically Competent Cells include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Chemically Competent Cells market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Chemically Competent Cells, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Chemically Competent Cells, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Chemically Competent Cells revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Chemically Competent Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Chemically Competent Cells revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc.
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells
Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Chemically Competent Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemically Competent Cells companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemically Competent Cells revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemically Competent Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cloned Competent Cells
1.2.3 Agrobacterium tumefaciens Competent Cells
1.2.4 Expression Competent Cells
1.3 Market by Application
1.3.1 Global Chemically Competent Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable Dna Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded Dna Production
1.3.9 Bacmid creation
1.3.10 Cre-lox recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemically Competent Cells Market Perspective (2018-2029)
2.2 Global Chemically Competent Cells Growth Trends by Region
2.2.1 Chemically Competent Cells Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chemically Competent Cells Historic Market Size by Region (2018-2023)
2.2.3 Chemically Competent Cells Forecasted Market Size by Region (2024-2029)
2.3 Chemically Competent Cells Market Dynamics
2.3.1 Chemically Competent Cells Industry Trends
2.3.2 Chemically Competent Cells Market Drivers
2.3.3 Chemically Competent Cells Market Challenges
2.3.4 Chemically Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Chemically Competent Cells by Players
3.1.1 Global Chemically Competent Cells Revenue by Players (2018-2023)
3.1.2 Global Chemically Competent Cells Revenue Market Share by Players (2018-2023)
3.2 Global Chemically Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Chemically Competent Cells, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Chemically Competent Cells Market Concentration Ratio
3.4.1 Global Chemically Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemically Competent Cells Revenue in 2022
3.5 Global Key Players of Chemically Competent Cells Head office and Area Served
3.6 Global Key Players of Chemically Competent Cells, Product and Application
3.7 Global Key Players of Chemically Competent Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemically Competent Cells Breakdown Data by Type
4.1 Global Chemically Competent Cells Historic Market Size by Type (2018-2023)
4.2 Global Chemically Competent Cells Forecasted Market Size by Type (2024-2029)
5 Chemically Competent Cells Breakdown Data by Application
5.1 Global Chemically Competent Cells Historic Market Size by Application (2018-2023)
5.2 Global Chemically Competent Cells Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chemically Competent Cells Market Size (2018-2029)
6.2 North America Chemically Competent Cells Market Size by Type
6.2.1 North America Chemically Competent Cells Market Size by Type (2018-2023)
6.2.2 North America Chemically Competent Cells Market Size by Type (2024-2029)
6.2.3 North America Chemically Competent Cells Market Share by Type (2018-2029)
6.3 North America Chemically Competent Cells Market Size by Application
6.3.1 North America Chemically Competent Cells Market Size by Application (2018-2023)
6.3.2 North America Chemically Competent Cells Market Size by Application (2024-2029)
6.3.3 North America Chemically Competent Cells Market Share by Application (2018-2029)
6.4 North America Chemically Competent Cells Market Size by Country
6.4.1 North America Chemically Competent Cells Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Chemically Competent Cells Market Size by Country (2018-2023)
6.4.3 North America Chemically Competent Cells Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Chemically Competent Cells Market Size (2018-2029)
7.2 Europe Chemically Competent Cells Market Size by Type
7.2.1 Europe Chemically Competent Cells Market Size by Type (2018-2023)
7.2.2 Europe Chemically Competent Cells Market Size by Type (2024-2029)
7.2.3 Europe Chemically Competent Cells Market Share by Type (2018-2029)
7.3 Europe Chemically Competent Cells Market Size by Application
7.3.1 Europe Chemically Competent Cells Market Size by Application (2018-2023)
7.3.2 Europe Chemically Competent Cells Market Size by Application (2024-2029)
7.3.3 Europe Chemically Competent Cells Market Share by Application (2018-2029)
7.4 Europe Chemically Competent Cells Market Size by Country
7.4.1 Europe Chemically Competent Cells Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Chemically Competent Cells Market Size by Country (2018-2023)
7.4.3 Europe Chemically Competent Cells Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Chemically Competent Cells Market Size (2018-2029)
8.2 China Chemically Competent Cells Market Size by Type
8.2.1 China Chemically Competent Cells Market Size by Type (2018-2023)
8.2.2 China Chemically Competent Cells Market Size by Type (2024-2029)
8.2.3 China Chemically Competent Cells Market Share by Type (2018-2029)
8.3 China Chemically Competent Cells Market Size by Application
8.3.1 China Chemically Competent Cells Market Size by Application (2018-2023)
8.3.2 China Chemically Competent Cells Market Size by Application (2024-2029)
8.3.3 China Chemically Competent Cells Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Chemically Competent Cells Market Size (2018-2029)
9.2 Asia Chemically Competent Cells Market Size by Type
9.2.1 Asia Chemically Competent Cells Market Size by Type (2018-2023)
9.2.2 Asia Chemically Competent Cells Market Size by Type (2024-2029)
9.2.3 Asia Chemically Competent Cells Market Share by Type (2018-2029)
9.3 Asia Chemically Competent Cells Market Size by Application
9.3.1 Asia Chemically Competent Cells Market Size by Application (2018-2023)
9.3.2 Asia Chemically Competent Cells Market Size by Application (2024-2029)
9.3.3 Asia Chemically Competent Cells Market Share by Application (2018-2029)
9.4 Asia Chemically Competent Cells Market Size by Region
9.4.1 Asia Chemically Competent Cells Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Chemically Competent Cells Market Size by Region (2018-2023)
9.4.3 Asia Chemically Competent Cells Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Chemically Competent Cells Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Type
10.2.1 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Chemically Competent Cells Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Application
10.3.1 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Chemically Competent Cells Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Country
10.4.1 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Chemically Competent Cells Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Chemically Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Chemically Competent Cells Business (2018-2023)
11.1.5 Merck KGaA Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Chemically Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Chemically Competent Cells Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Chemically Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Chemically Competent Cells Business (2018-2023)
11.3.5 Agilent Technologies Recent Developments
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Chemically Competent Cells Introduction
11.4.4 Takara Bio Revenue in Chemically Competent Cells Business (2018-2023)
11.4.5 Takara Bio Recent Developments
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Chemically Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Chemically Competent Cells Business (2018-2023)
11.5.5 Promega Corporation Recent Developments
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Chemically Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Chemically Competent Cells Business (2018-2023)
11.6.5 Beijing TransGen Biotech Recent Developments
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Chemically Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Chemically Competent Cells Business (2018-2023)
11.7.5 GeneScript Corporation Recent Developments
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Chemically Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Chemically Competent Cells Business (2018-2023)
11.8.5 Yeastern Biotech Recent Developments
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Chemically Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Chemically Competent Cells Business (2018-2023)
11.9.5 New England Biolabs Recent Developments
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Chemically Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Chemically Competent Cells Business (2018-2023)
11.10.5 QIAGEN N.V. Recent Developments
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Chemically Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Chemically Competent Cells Business (2018-2023)
11.11.5 OriGene Technologies Recent Developments
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Chemically Competent Cells Introduction
11.12.4 Lucigen Revenue in Chemically Competent Cells Business (2018-2023)
11.12.5 Lucigen Recent Developments
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Chemically Competent Cells Introduction
11.13.4 Zymo Research Revenue in Chemically Competent Cells Business (2018-2023)
11.13.5 Zymo Research Recent Developments
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Chemically Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Chemically Competent Cells Business (2018-2023)
11.14.5 Bio-Rad Laboratories Recent Developments
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Chemically Competent Cells Introduction
11.15.4 Bioline Revenue in Chemically Competent Cells Business (2018-2023)
11.15.5 Bioline Recent Developments
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Chemically Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Chemically Competent Cells Business (2018-2023)
11.16.5 Delphi Genetics Recent Developments
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Chemically Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Chemically Competent Cells Business (2018-2023)
11.17.5 IBA GmBH Recent Developments
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Chemically Competent Cells Introduction
11.18.4 Cell Applications Revenue in Chemically Competent Cells Business (2018-2023)
11.18.5 Cell Applications Recent Developments
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Chemically Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Chemically Competent Cells Business (2018-2023)
11.19.5 BioDynamics Laboratory Recent Developments
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Chemically Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Chemically Competent Cells Business (2018-2023)
11.20.5 Scarab Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Ìý
Ìý
*If Applicable.
